Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection
about
Current and emerging pharmacologic options for the management of patients with chronic and acute decompensated heart failure.Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats.Morphine in acute heart failure.European Heart Journal-Cardiovascular Pharmacotherapy in 2016: entering a new level of international recognition.
P2860
Serelaxin for the treatment of acute heart failure: a review with a focus on end-organ protection
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Serelaxin for the treatment of ...... focus on end-organ protection
@ast
Serelaxin for the treatment of ...... focus on end-organ protection
@en
Serelaxin for the treatment of ...... focus on end-organ protection
@nl
type
label
Serelaxin for the treatment of ...... focus on end-organ protection
@ast
Serelaxin for the treatment of ...... focus on end-organ protection
@en
Serelaxin for the treatment of ...... focus on end-organ protection
@nl
prefLabel
Serelaxin for the treatment of ...... focus on end-organ protection
@ast
Serelaxin for the treatment of ...... focus on end-organ protection
@en
Serelaxin for the treatment of ...... focus on end-organ protection
@nl
P2860
P921
P356
P1476
Serelaxin for the treatment of ...... focus on end-organ protection
@en
P2093
Javier Díez
P2860
P304
P356
10.1093/EHJCVP/PVV046
P407
P5008
P577
2016-04-01T00:00:00Z